ASHG denounces the misuse of genetics to feed racist ideologies, and affirms that the research community should be clear about genetic knowledge related to ancestry and genomic diversity. Any attempt to use genetics to rank populations demonstrates a fundamental misunderstanding of genetics. Related: AJHG Perspective: ASHG Denounces Attempts to Link Genetics and Racial Supremacy (November... Read More
In 2018, a legislative amendment was proposed that would protect the genetic privacy of immigrant families by restricting the use of their genetic material and data to helping reunify family members. The amendment would require that government officials restrict their use of DNA analysis to when it is truly needed and ensure that biological samples... Read More
Sarah A. Gagliano, ASHG: What is the focus of your research? Dr. Zeggini: My research uses large-scale biomedical data to identify genetic causes of complex traits, with a primary focus on musculoskeletal diseases and cardiometabolic traits. Our activities are underpinned by the development of methods to advance statistical genetics approaches. ASHG: What aspects of your... Read More
Founder DNASimple Dr. Noel was recently recognized in Forbes’ 30 Under 30 Science list and received a $200,000 investment on ABC’s Shark Tank for his company. Burcu Darst, ASHG: Could you tell us about your company, DNAsimple? Dr. Noel: DNAsimple is a marketplace where researchers, particularly those in genetics/genomics, can find and obtain DNA and other specimens from the... Read More
In 2018, the U.S. Food and Drug Administration (FDA) invited comments on its intention to exempt a list of class II devices from premarket notification requirements, including tests assessing genetic health risks. ASHG responded to this request for comment by outlining its support for regulation that brings scientifically valid, evidence-based tests to market, and expressing... Read More
ASHG uses cookies to provide you with a secure and custom web experience. Privacy Policy